Healthcare / Medical Care FacilitiesIstanbul
$25.78
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 19%
FCF escenarios
weak_data · normalized FCF $299.6M · quality 46.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
64/100
B
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$10.3B
P/E
15.2x
↓EV/EBITDA
7.9x
↓ROE
8.7%
↑Gross Margin
41.0%
↓Debt/Equity
0.05
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+47.2%
FCF CAGR
+336.6%
FCF margin
8.7%
FCF / Net income
0.43x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $3.43B · net income $695.7M · FCF $299.6M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $3.43B | $3.43B | $2.86B | $1.90B | $1.07B |
| Net Income | $695.7M | $695.7M | $1.65B | $1.19B | $266.1M |
| EBITDA | $1.27B | $1.27B | $3.49B | $1.68B | $406.4M |
| EPS | 1.74 | 1.74 | 4.12 | 2.97 | 0.67 |
| Gross Margin | 41.0% | 41.0% | 36.2% | 27.6% | 23.2% |
| Operating Margin | 28.4% | 28.4% | -3.3% | 12.4% | 15.7% |
| Net Margin | 20.3% | 20.3% | 57.6% | 62.7% | 24.8% |
| Balance Sheet | |||||
| Debt/Equity | 0.05 | 0.05 | 0.09 | 0.24 | 0.03 |
| Current Ratio | 2.37 | 2.37 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $299.6M | $299.6M | $-1.05B | $340.6M | $3.6M |
| Returns | |||||
| ROE | 8.7% | 8.7% | 23.0% | 26.5% | 14.9% |
| Valuation | |||||
| P/E | 15.16 | 15.16 | 4.49 | 6.51 | — |
| EV/EBITDA | 7.86 | 7.86 | 2.21 | 4.85 | — |
| P/B | 1.29 | 1.29 | 1.03 | 1.72 | — |
| Growth & Yield | |||||
| Revenue Growth | 19.8% | 19.8% | 51.1% | 76.4% | — |
| EPS Growth | -57.8% | -57.8% | 38.8% | 346.3% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
9.5%
EPS terminal req.
$2.29
Spread vs growth
-67.3%
5Y implied EPS CAGR
9.7%
EPS terminal req.
$2.77
Spread vs growth
-67.5%
10Y implied EPS CAGR
9.9%
EPS terminal req.
$4.46
Spread vs growth
-67.6%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+29.1%
Start / end P/E
4.7x → 14.5x
EPS bridge
4.12 → 1.74
Residual
-118.9%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.